Treatment of proteinuria with lercanidipine associated with reninangiotensin axis-blocking drugs by N. R. Robles, B. Romero, E. Garcia de Vinuesa, E. Sánchez-Casado, J. J. Cubero

Get full text

Lercanidipine in general practice settings: safety and effectiveness. The LAPSE Study results by N. R. Robles, J. A. Canelada, M. Iglesias, E. Angulo, A. López Acedo, E. Díaz Olea, F. Cidoncha, M. Guerras, J. Fuentes, J. Garrido, J. Lapie, J. Peña, A. Aguilar, P. Hidalgo

Get full text

Lercanidipine in patients with chronic renal failure: the ZAFRA Study by N. R. Robles, J. Ocon, C. F. Gomez, M. Manjon, L. Pastor, J. Herrera, J. Villatoro, J. Calls, J. Torrijos, V. I. Rodríguez, M. M. A. Rodriguez, M. L. Mendez, A. Morey, F. I. Martinez, J. Marco, A. Liebana, B. Rincon, F. Tornero

Get full text